Effect of lipid-lowering medications in patients with coronary artery bypass grafting surgery outcomes

BMC Anesthesiology

Table 3 Association between lipid-lowering treatment and postoperative complication and mortality after propensity weighted risk-adjustment

Outcomes	OR	Coefficient	95%CI	P value
In-hospital complication	0.856		0.781–0.938	< 0.001
Infection	1.223		0.795–1.890	0.361
Stroke	0.481		0.349–0.654	< 0.001
Neurologic complication	0.572		0.441–0.739	< 0.001
Ventilation prolonged	0.915		0.809–1.-35	0.156
Renal failure	0.989		0.795–1.232	0.922
Renal dialysis	1.245		0.896–1.736	0.192
New onset AF	1.024		0.925–1.134	0.645
In-hospital Mortality	0.616		0.432–0.869	0.006
30-day Mortality	0.789		0.563–1.101	0.165
Overall Mortality	0.723		0.634–0.824	< 0.001
Total ICU hours		-12.985	-28.120–2.150	0.093
Length of hospital stay		0.491	-1.000–1.983	0.518

OR odds ratio, AF atrial fibrillation, ICU intensive care unit, CI confidence interval

ISSN: 1471-2253